Introduction: Who Should Seek Diagnostic Testing

If you experience chest pain or discomfort, especially if it occurs at rest or during the night, you should seek medical evaluation. This is particularly important if the pain feels intense, appears on the left side of your chest, or spreads to your neck, arms, jaw, or back. Coronary artery spasm can present symptoms similar to a heart attack, and only proper testing can distinguish between these conditions.^[1]

Diagnostic testing is especially advisable if you have risk factors for heart disease, including high blood pressure, high cholesterol, or a history of tobacco use. However, many people who experience coronary artery spasms do not have traditional heart disease risk factors, which makes the condition more difficult to identify based on risk assessment alone. Those who use stimulant drugs such as amphetamines or cocaine should be particularly vigilant, as these substances are known triggers for arterial spasms.^[2]

The condition can also affect younger individuals, typically between ages 40 and 70, although it tends to decrease after age 70. The symptoms often follow a pattern, occurring predominantly at rest and usually in the early morning hours, which is different from typical angina that occurs with physical activity. If you notice chest pain that wakes you up at night or happens repeatedly at similar times, this pattern itself is a reason to pursue diagnostic evaluation.^[3]

Women should be aware that coronary artery spasm symptoms can sometimes be linked to the menstrual cycle, adding another layer of complexity to recognizing the condition. Anyone experiencing recurrent chest discomfort, whether frequent or infrequent, should discuss these episodes with their healthcare provider to determine if diagnostic testing is appropriate.^[5]

Classic Diagnostic Methods

To diagnose coronary artery spasm, healthcare providers use several tests that evaluate heart health and function. The goal is to identify whether the arteries are experiencing temporary constriction and to rule out other causes of chest pain, such as blockages from cholesterol plaque buildup.

Electrocardiogram (ECG or EKG)

An electrocardiogram, commonly called an ECG or EKG, is often the first test performed when evaluating chest pain. This test measures your heart’s electrical signals and can detect patterns consistent with reduced blood flow to the heart muscle. During a coronary artery spasm, the ECG typically shows distinctive changes. In classic cases, it displays ST-segment elevation, which indicates that a complete or near-complete blockage is affecting the full thickness of the heart muscle wall. In other cases, the ECG might show ST-segment depression, suggesting a partial blockage or that collateral blood vessels are providing some backup circulation.^[7]

The challenge with ECG testing is that coronary artery spasms are temporary and unpredictable. If you have the test when the spasm is not occurring, the results may appear normal. This is why timing matters greatly in diagnosis, and your healthcare provider may need to order the test during or immediately after an episode of chest pain to capture meaningful changes.^[1]

Ambulatory Monitoring

Because coronary artery spasms often occur at night or during early morning hours, your healthcare provider may give you an ambulatory monitor to wear at home. This portable device continuously records your heart’s electrical activity as you go about your daily activities and while you sleep. The monitor provides a more comprehensive view of your heart rhythm over 24 hours or longer, increasing the chances of capturing a spasm episode when it actually occurs. This can be particularly important since spasms frequently happen during rest periods rather than during medical appointments.^[1]

Echocardiogram

An echocardiogram, often shortened to echo test, uses sound waves to create moving pictures of your heart. This test can show how well your heart chambers and valves are working and whether the heart muscle is moving normally. During or immediately after a spasm, an echocardiogram might reveal areas of the heart that are not contracting properly due to reduced blood flow. However, like the ECG, this test may appear normal if performed when no spasm is present.^[1]

Coronary Angiography

Coronary angiography is a more invasive test that uses special dye and imaging scans to watch how blood flows through your heart arteries. A thin tube called a catheter is inserted into an artery, usually in your wrist or groin, and guided to your heart. Dye is then injected through the catheter, and X-ray images are taken as the dye moves through your coronary arteries. This test is particularly valuable because it can distinguish coronary artery spasm from the more common cause of chest pain: arteries blocked by cholesterol plaque.^[1]

In someone experiencing typical angina from blocked arteries, the angiogram will show one or more arteries narrowed by plaque. In someone with coronary artery spasm, however, the coronary arteries may look clear and healthy on the angiogram when no spasm is present. The spasm can occur in arteries that have some plaque buildup or in completely normal-looking vessels. This finding of chest pain with clear arteries often prompts further investigation to confirm vasospasm as the cause.^[6]

Provocative Testing

When other tests do not provide a clear diagnosis, doctors may use provocative testing to intentionally trigger a spasm in a controlled medical setting. The most frequently used provocative tests involve administering medications through the coronary arteries during an angiography procedure. Two common agents used are acetylcholine (ACh) and ergonovine.^[7]

These medications are given in carefully controlled doses while the doctor monitors your heart function and watches the coronary arteries on imaging. If you have a tendency toward coronary artery spasm, these agents will trigger a temporary constriction of the arteries that can be observed and documented. The test is performed in a hospital setting where the spasm can be immediately reversed with medications if needed. This testing helps confirm the diagnosis when clinical symptoms suggest spasm but other tests have been inconclusive.^[6]

Provocative testing has shown that coronary artery spasm is more common than previously thought. One German study found that among patients suspected of having coronary artery disease but with no obvious blockage, 50% were confirmed to have coronary artery spasm when tested with acetylcholine. This suggests that many cases may go undiagnosed without proper testing.^[3]

Diagnostics for Clinical Trial Qualification

When patients are being considered for enrollment in clinical trials studying coronary artery spasm or related conditions, additional diagnostic criteria may be required beyond standard clinical diagnosis. Clinical trials typically have strict inclusion and exclusion criteria to ensure that participants truly have the condition being studied and that the trial results will be meaningful.

For clinical trials focusing on coronary artery spasm, documentation of the condition through objective testing is usually required. This often means that patients must have documented ECG changes during chest pain episodes showing the characteristic ST-segment elevation or depression. Some trials may require ambulatory ECG monitoring that has captured these episodes, providing recorded proof of the electrical changes in the heart during symptoms.^[7]

Coronary angiography findings are frequently part of trial qualification criteria. Researchers may need to document whether the patient has spasm in arteries with existing plaque or in angiographically normal vessels. They might also need to classify whether the spasm is focal (affecting one or a few segments) or diffuse (affecting larger portions of the coronary arteries). This level of detail helps researchers study whether different patterns of spasm respond differently to treatments.^[7]

Many clinical trials require confirmation of coronary artery spasm through provocative testing with acetylcholine or ergonovine. This ensures that participants truly have hyperreactive coronary arteries rather than some other cause of chest pain. The testing protocols for trials are often standardized, with specific doses of provocative agents and defined criteria for what constitutes a positive test result. A positive result typically means that the coronary artery narrows by a certain percentage (often 75% or more) in response to the medication, accompanied by chest pain and ECG changes.^[6]

Trial protocols may also require documentation that patients do not have severe blockages from cholesterol plaque, as this could confuse the interpretation of study results. Blood tests might be performed to measure cholesterol levels, markers of inflammation, or other factors that could influence the disease or response to treatment. Some trials investigating the underlying mechanisms of coronary artery spasm might require genetic testing to look for inherited factors that increase susceptibility to arterial spasms.^[3]

Functional assessments are often part of trial qualification. Patients may need to undergo stress testing or exercise testing to see if physical activity triggers their symptoms and to establish a baseline level of exercise tolerance. This information helps researchers measure whether experimental treatments improve patients’ ability to engage in daily activities without symptoms.

Documentation of symptom frequency and severity is another common requirement. Patients may need to keep detailed diaries recording when chest pain occurs, how long it lasts, what triggers it, and how severe it feels. Some trials require that patients experience a minimum number of episodes per week or month to be eligible, ensuring that there are enough events to measure whether a treatment is working.

Quality of life assessments are increasingly included in trial qualification criteria. Researchers want to ensure that the condition significantly affects patients’ daily lives and that any improvement from treatment will be meaningful. Patients may complete questionnaires about their physical functioning, emotional well-being, and ability to work or perform household tasks.

Exclusion criteria are equally important in clinical trials. Patients may be excluded if they have other serious heart conditions, uncontrolled high blood pressure, recent heart attack, or other medical problems that could make participation unsafe or interfere with study results. Some trials exclude patients who smoke or use recreational drugs, while others may include these patients but track these factors as part of the study data.